Medicine shortages are a global problem caused by multiple factors, including raw material shortages, manufacturing issues, and industry consolidations, affecting the supply chain and various stakeholders.

The global medication shortage problem is attributed to pharmaceutical companies prioritizing short-term profits, resulting in a mismatch between drug production and demand.

The global medication shortage is caused by pharmaceutical companies' reliance on foreign suppliers and their prioritization of profitable products over essential generic drugs.

The global medication shortage problem is attributed to restrictions on generic drug supply and low investment returns in new drugs.

The global medication shortage problem is attributed to a combination of factors, including the lack of supply from international pharmaceutical companies, low drug prices driven by health insurance systems, and inadequate support from the Ministry of Health and Welfare for domestic pharmaceutical companies.

"The United States is experiencing a severe shortage of medicines and drugs, with over 135 drugs in short supply."

Taiwan is experiencing a severe shortage of medicines and drugs, with 131 medicines currently out of stock.

"The United States is experiencing a severe shortage of medicines and drugs, with 323 medical drugs currently in short supply, the worst since 2001."

"The United States is experiencing a severe shortage of medicines and drugs, with the FDA reporting 111 drug shortages."

"The United States is experiencing a severe shortage of medicines and drugs, with a 30% increase in shortages last year compared to 2021."

Taiwan is experiencing a medication shortage, with 131 medicines out of stock, including common medications like amoxicillin and acetaminophen.

Medications such as magnesium oxide, Ammonicillin, and acetaminophen painkillers are still in short supply in Taiwan, posing a risk to first-line medical care.

Carboplatin and cisplatin, used in cancer treatments, have been in short supply, with 93% and 70% of treatment centers reporting shortages, respectively.

One of the challenges in the healthcare system is the unfair pricing mechanism, which makes medicine inaccessible to many people, particularly those not participating in the health insurance system.

One of the challenges in the healthcare system is a significant shortage of nurses.

The healthcare system is facing challenges such as supply chain disruptions and staff vacancies, which can impact the availability of medications.

"Cancer medications, including cisplatin and carboplatin, are among the types of medications affected by shortages, with over a dozen cancer drugs experiencing shortages in recent months."

Medications affected by shortages include carboplatin, cisplatin, steroids, hormonal drugs, and oral liquids such as lidocaine, ibuprofen, and amoxicillin.

"The medication shortage affects over 135 drugs, including chemotherapy drugs for cancer, as reported by the FDA."

"Medications such as amoxicillin, acetaminophen, magnesium oxide, and ibuprofen are affected by shortages, with a total of 131 medicines out of stock in Taiwan."

Medication shortages affect all drug classes, with the most concerning being sterile injectable generic drugs, including cancer chemotherapy and emergency drugs.

The supply of pharmaceuticals has been affected by several factors, including the Covid pandemic, the war in Ukraine, the energy crisis, inflation, and Brexit, which have contributed to global drug shortages.

The supply of pharmaceuticals has been affected by factors such as the Ukrainian war, which caused supply gaps, and changes in manufacturing decisions when pharmaceutical companies change ownership.

"The COVID-19 pandemic has caused delayed production by major manufacturers, leading to a shortage of pharmaceuticals, including Adderall. Pharmaceutical companies are reluctant to disclose the cause of the drug supply shortage."

The supply of pharmaceuticals has been affected by the coronavirus pandemic, leading to shortages of certain medicines, including antipyretic drugs, in countries like China, Singapore, and Hong Kong.

Cancer medications, including cisplatin and carboplatin, are among those affected by the shortage in the US, posing risks to patients with lung, breast, prostate, and gynecologic cancers.

"The US is experiencing a shortage of over 135 drugs, including chemotherapy and ADHD medications."

The medication shortage in the US affects various drug classes, with sterile injectable generic drugs, such as cancer chemotherapy and emergency drugs, being particularly impacted.

"The medication shortage in the US affects various types, including chemotherapy drugs, central nervous system stimulants, antimicrobials, hormonal agents, and intravenous fluids."

"The US is experiencing a shortage of 323 medical drugs, including general injection disinfection drugs, cancer chemotherapy drugs, and emergency medicine stores, affecting various types of medications."

Generic medicines are available as an alternative to brand-name medications in case of supply issues.

The text mentions generic drugs as an alternative to brand-name medications, specifically highlighting Teva, the world's largest generic drug manufacturer, and its decision to reduce production of some generic drugs.

Medications such as oral morphine, ibuprofen, aspirin, and paracetamol have been affected by shortages, with France experiencing a shortage of paracetamol products and Great Britain facing low drug imports from the EU.

Government price controls, which slashed the price of drugs, led to a shortage of medications as local pharmaceutical companies became less willing to produce low-cost drugs.

Government price controls may be contributing to medication shortages in Egypt, as manufacturers struggle to produce medicines at low enough costs to be profitable.

Government price controls may contribute to medication production shortages by limiting the supply price of generic drugs and reducing the return on investment in new drugs.

Medicine shortages are a global problem caused by multiple factors, including raw material shortages, manufacturing issues, and industry consolidations, affecting the supply chain and various stakeholders.

Title:

Content: Ireland has been suffering a paracetamol shortage as cases of Covid-19 and the winter flu in the country soared over the festive and new year period.

The revelation was made by Health Minister Stephen Donnelly after his department received notification of a supply issue from the Health Products Regulatory Authority.

It is understood the shortage impacted some prescription paracetamol products.

Read More:Irish people complain of ‘worst ever’ winter bug sweeping country that feels like Covid but isn’t

Two suppliers affected have stated that resupply will be sometime in January 2023.

However, there are other prescription paracetamol suppliers with some stock available on the shelves.

Paracetamol is one of the medicines used most often in Ireland and especially for the flu, aches and pain.

But Mr Donnelly pointed out that there are multiple forms of the drug with different strengths and brands available from various sources.

He said: "In the event that there are some supply issues for individual medicines, alternative options such as alternative strengths and brands, generic medicines will usually be available to ensure continuity of treatment.

"In some cases where the medicine initially prescribed for the patient is unavailable, patients may be switched to a suitable therapeutic alternative following appropriate consultation with a healthcare professional."

The Health Minister said medicine shortages have been increasingly prevalent worldwide over the past decade. The causes of such shortages are multifactorial including shortage of raw materials, manufacturing difficulties and industry consolidations.

He stated: "Medicine shortages can originate at any point in the supply chain. They can involve and impact many stakeholders in different ways as the supply models and clinical use of therapies can vary across national health systems.

"Management of medicines shortages necessitates a multi-faceted, multi stakeholder response to ensure patient safety , continuity of care and protection of public health.

"Patients or their carers who have any concerns in relation to temporary alternative products provided because of medical shortages are advised to speak with their pharmacist or other healthcare [professionals] involved in their care."

Mr Donnelly was responding to a number of written Dail questions on the shortage of medicines.

READ NEXT:

Get breaking news to your inbox by signing up to our newsletter

The global medication shortage problem is attributed to pharmaceutical companies prioritizing short-term profits, resulting in a mismatch between drug production and demand.

Title:

Content: International
International News
Dependent on foreign raw materials fluctuate, big pharmaceutical companies chase short-term profit loss production
The shortage of ADHD drugs is just the tip of the iceberg of the current drug shortage in the United States. According to the FDA, more than 135 drugs are in short supply, including chemotherapy drugs for cancer.
A survey released by the American Society of Health System Pharmacists (ASHP) in early August showed that one-third of the 1,100 hospitals surveyed had no prescription, delayed or reduced prescriptions due to drug shortages to meet the supply window.
Expert analysis, pharmaceutical companies to pursue short-term profit first business model, so that the production of life-saving drugs and demand out of line, drug shortage problem is difficult to improve.
Experts urge pharmaceutical companies to face social responsibility
Rita Numerof, a medical industry consultant, wrote in Forbes magazine that in order to reduce costs, US pharmaceutical companies have long relied on foreign suppliers such as China, India and Italy to import raw materials for the production of drugs, which is prone to fluctuations in supply. They are looking to develop drugs that are more likely to be used for long-term diseases.
Teva, a manufacturer of ADHD drugs and the world ’ s largest generic drug manufacturer, announced earlier that it would reduce the production of some generic drugs and focus on more profitable products. Rumelove warned that if pharmaceutical companies are unwilling to address their social responsibilities and strengthen supply risk management, public trust in the pharmaceutical industry will continue to weaken, and ultimately public health and safety will pay a heavy price.
Focus on the organization to accelerate the use of new generic drugs to increase production incentives
The American Association for Access to Medicines (AAM) released a report last month, saying that because of restrictions on the supply of generic drugs, the supply price of generic drugs is limited, and the return of investment in new drugs is not high. The situation.
(Forbes / DrugTopics)
(Global Hot Talk)
Related Words: Adderall Drug Shortage Attention Deficit and Hyperactivity Disorder (ADHD)
Previous / Next News

The global medication shortage is caused by pharmaceutical companies' reliance on foreign suppliers and their prioritization of profitable products over essential generic drugs.

The global medication shortage problem is attributed to restrictions on generic drug supply and low investment returns in new drugs.

The global medication shortage problem is attributed to a combination of factors, including the lack of supply from international pharmaceutical companies, low drug prices driven by health insurance systems, and inadequate support from the Ministry of Health and Welfare for domestic pharmaceutical companies.

Title:

Content: The Kuomintang group calls on Chen Chien-jen to take over the government's national security crisis
REPORTER WENG Tzu-kun / Taipei Report
The shortage of drugs in the country continues to burn, the Kuomintang Legislative Yuan group today (1) a press conference called on the Tsai government, do not just want to vote all day, more concerned about the people's health rights, if the Minister of Health and Welfare Xue Ruiyuan, the Food and Drug Administration Director Wu Xiumei do not do well, it will be cut off.
The KMT further demanded that the "Drug Deficiency Monitoring Center" be raised to the level of the Executive Yuan, and called on Premier Chen Jianren to take over the management and treat it as a national security level issue.
This is an advertisement, please continue reading.
The Kuomintang group today opened a "shortage of drugs! shortage of drugs! When?" press conference, the general convenor Zeng Mingzong said that the shortage of drugs is a structural problem, health insurance to slash the price of drugs, so that the shortage of drugs crisis expanded, local pharmaceutical companies are more reluctant to produce low-cost drugs.
And some people complained, ran 10 drug bureaus did not receive drugs, beat the table to scolding, so that the community pharmacist pressure is great.
Zeng Mingzong pointed out that, for example, muscle relaxants reported a shortage of drugs on March 8, 2021, compound antibiotics, anti-fever pain tablets reported a shortage of drugs on June 6, 2022, blood pressure drugs reported a shortage of drugs on August 25, 2022, blood lipid-lowering drugs reported a shortage of drugs on August 26, 2022. In addition to the election, Tsai's government also cares about the health of the nation's people.
Zeng Mingzong said that the Kuomintang group humbly asked the Tsai government, the current lack of eggs, water, and medicine in the country, the people are asking the government what is wrong? Impairment! Failure! Please the government to come up with a specific plan to solve the problem of shortage of drugs, and ensure the basic health rights of 23 million people.
Hsieh Ying-yi, secretary-general, says that recent shortages of amoxicillin, acetaminophen, magnesium oxide, and ibuprofen in primary pharmacies and clinics have revealed that there are 131 medicines out of stock in Taiwan.
She stressed that in order to solve the problem of drug shortage, the community pharmacy has also set up a "mutual aid association" to find drugs in the way of drug exchange.
He bluntly said that this is a serious national security problem, will it make the burden of health care more heavy?
For a long time, the total amount of health insurance system has been driving down drug prices, but international pharmaceutical companies are facing a global shortage of goods, and will not give priority to imports to Taiwan.
When the National Health Insurance Administration wants to solve the unreasonable drug price difference, does it also solve the problem of drug prices that do not meet the cost?
Xie Yifeng also pointed out that on February 11, Xue Ruiyuan urgently convened a meeting on shortage of drugs, and resolved to persuade drug manufacturers to increase production capacity. If it is not possible to increase production capacity, then strengthen the allocation of hospitals and clinics to pharmacies to solve the problem of shortage of drugs.
How does the Ministry of Health and Welfare assist domestic pharmaceutical companies in obtaining raw materials and mass-producing pharmaceutical products?
Not at all.
Shouldn ’ t the Ministry of Health and Welfare convene meetings across ministries, industries, and pharmaceuticals to coordinate and solve problems?
Hsieh Yi-hung lambasted that after the meeting of the Ministry of Health and Welfare, nothing had been done, and such a meeting would not be held.
The Ministry of Health and Welfare will increase the burden of health insurance to 120 million yuan on April 1, which is expected to affect 1.17 million people.
Please ask Chen Chien-jen and the Ministry of Health and Welfare, in the special budget after the epidemic, to allocate 20 billion yuan for health insurance, why do you need to increase part of the burden?
The Ministry of Health and Welfare should first solve the problem of lack of medicines, and do not want to spend money from the pockets of the people.
On March 29, 2019, Wu Xiumei, who is responsible for managing the national drug administration department, held a meeting on “Drug Shortage ”. The results of the expert meeting on the evaluation of the operation and follow-up mechanism of the meeting were only based on the meeting and the meeting was postponed, and the decisions made after the meeting were not implemented.
"Taiwan's lack of medicine is a problem of management." Lai Shibao pointed out that the Ministry of Health and Welfare has constantly justified itself with problems such as rising raw materials and the Russian-Ukrainian war, but the whole world is affected, and Taiwan alone has a shortage of medicine.
In 1999, the US FDA established a “Drug Deficiency Monitoring Center ”, which stipulates that any drug that is less than 6 months in stock must be monitored and taken countermeasures.
Lai Shih-pao points out that the pharmaceutical and medical sectors in Taiwan have long called on the government to do the same.
Lai Shih-pao also suggested that Chen Chien-jen, the National Health Insurance Administration (NHIA) plans to slash the health insurance drug budget by NT $8.1 billion. Please ask the so-called warm and tenacious cabinet to start caring for humanity and solve the problem of shortage of drugs as soon as possible.
In 2016, Tsai Ying-ying told pharmacists at the All-Union Congress of Pharmacists that it was necessary to make medicines available to the people and replace them with social medicines in 2018. The result was still a shortage of drugs.
Yang Qiong said that magnesium oxide mainly treats gastric and esophageal reflux and constipation, is a common chronic prescription drug. Patients need to use drugs every day. Does the government know? In addition, the first-line commonly used antibiotics Ammonicillin and acetaminophen painkillers are lacking, which increases the risk of physical collapse of first-line medical care.
The government does not know what the problem is, and even the drugs have to go back to the original "drug-for-drugs" era, the "drug-for-drugs monitoring center" must be raised to the level of the Executive Yuan, immediately inventory 131 drug categories, immediately replenish, strengthen the monitoring mechanism, so that the people really have drugs available.
Dr. Shen Caiying, spokesman of the Taiwan Pharmaceutical Marketing and Management Association, said with emotion that Tsai Ing-wen had said that the society has drugs available, and the people will use drugs, which of course is also the responsibility of pharmacists.
During the epidemic, the Ministry of Health and Welfare relied heavily on community pharmacies to issue masks and rapid screening to take on the frontline public health mission, but the Ministry of Health and Welfare seemed indifferent to the serious problem of drug shortage.
Shen Caiying questioned the government, according to Article 15 of the "National Health Insurance Drug Price Adjustment Operation Measures", the directive drug is not allowed to have a floor price, but the Director of Health Insurance Shi Chongliang publicly stated that the directive drug should be set a floor price to solve the problem of drug shortage.
Shen Caiying said that for every US dollar used in the United States on the instructions, it can save 6 to 7 US dollars for health insurance, which can save 10.2 billion US dollars a year.
Shen Caiying suggested that the government, to solve the problem of shortage of drugs, please administer according to law, instruct that drugs should not be paid, cancel the daily drug charge, and pay.
The drug shortage center must combine relevant professional groups, patient groups, and pharmaceutical industry to jointly discuss the problem of drug shortage.
In addition, one of the four vice presidents of the Executive Yuan ’ s Commission for Sustainable Development is Minister Weifu. I wonder if the Minister of Weifu has told the Executive Yuan that there is a serious shortage of drugs?
Or do you want the community pharmacy to suffer silently?
This is an advertisement, please continue reading.

"The United States is experiencing a severe shortage of medicines and drugs, with over 135 drugs in short supply."

Taiwan is experiencing a severe shortage of medicines and drugs, with 131 medicines currently out of stock.

"The United States is experiencing a severe shortage of medicines and drugs, with 323 medical drugs currently in short supply, the worst since 2001."

Title:

Content: My channel
* Drag categories can be customized sorting
Recover Default OK
Setup
Alert
Murdered roommate, mutilated body hidden in apartment freezer, New York terror couple arrested
Inflation and Geopolitical Dow Drops 475 Points
The shortage of 323 medical drugs is the worst since 2001.
According to the American Society of Health-System Pharmacis (ASHP), 323 medical drugs are currently in short supply, breaking the previous record of 320 shortages in 2014 and the most severe since tracking drug shortages began in 2001.
ASHP ’ s collaborative survey with the Utah Drug Information Service found that drug shortages in the United States are increasing and show no signs of improvement.
The institute said that all kinds of drugs are at risk of being out of stock, and the most worrying is the lack of even general injection disinfection drugs, including cancer chemotherapy drugs, and emergency medicine stores in hospitals and surgery departments.
Adderall, which is used to treat ADHD and narcolepsy, is one of the most difficult drugs to track and has been in short supply since October 2022. The Drug Enforcement Administration said last fall that more than a dozen pharmaceutical companies said they intended to increase adderall production, but ASHP noted that the problem persists to this day.
Members of the Society of Pharmacists say there is a national shortage of drugs to treat ADHD, which is still causing problems for medical personnel and patients.
Adderall will be short of loans, one of the reasons is that during the Covid-19 period, the use of large, delayed production by major manufacturers, and other manufacturers can not meet production targets.
In its quarterly report, ASHP noted that most pharmaceutical companies are reluctant to disclose the cause of the drug supply shortage.
Experts believe that the rapid increase in demand, supply is too late, pharmaceutical companies are limited, and the supply chain of pharmaceutical materials is blocked.
Cancer Epidemic Health Insurance
The last one.
Watch out for mentally retarded wife, talk show host Jay Leno gets custody
The next one.
One dead, 13 injured, 18 trucks deliberately rammed the office building of the Texas Department of Public Security.
Extended reading
Super-popular
More >

"The United States is experiencing a severe shortage of medicines and drugs, with the FDA reporting 111 drug shortages."

Title:

Content: US supply chain crisis continues, FDA points to 111 drug shortages
Global Social Hotspot 16: 35 2021 / 12 / 05
Share:
The supply chain crisis in the United States continues, and many goods are facing shortages.
The US media said that the US pharmacies have a number of critical prescription drugs in stock. The US Food and Drug Administration (FDA) pointed out that about 111 drugs are out of stock in the United States. The FDA stressed that it will continue to take measures to monitor the supply chain.
【 Omicron variant 】 Travellers must have a negative test within 48 hours for entering the United Kingdom 【 Next 】
The Federal Reserve warned on Wednesday that large parts of the United States had begun to be affected by supply chain disruptions and labor shortages last month.
According to the FDA website, 111 drugs are out of stock in the United States, including the heart disease drug digoxin injection, the chemical drug Dacarbazine and some antibiotics.
The authorities say there are many reasons for the shortage, including production problems, quality problems, drugs and even the suspension of production.
According to the FDA, about 80% of the manufacturers of active pharmaceutical ingredients are located overseas, and the manufacturers have provided the FDA with most of the drug shortage information.
The Administration will also work closely with these manufacturers to address the drug shortage.
【 Omicron variant 】 Study: Omicron carries a cold virus gene or helps avoid the immune system 【 Next 】
Long Island Newspaper Newsday quoted Tom D'Angelo, president of the New York State Association of Pharmacists, as saying the shipping of a large number of medicines, including those for common blood pressure and for the treatment of colds and flu, was blocked.
Because of supply chain problems, the owner of a New York drugstore said there were fewer brands for some drugs, including Ibuprofen.
The National Association of Community Pharmacists (NCPA) released a survey last month that found that most non-chain pharmacies are struggling to fill employee vacancies and cope with supply chain disruptions.
Sixty percent of pharmacies surveyed said they were dealing with supply chain disruptions, and nearly 70 percent said it was difficult to fill staff vacancies.
Stay abreast of the latest development of mutant virus and epidemic vaccine, download the Hong Kong Economic Times App for free now 【 Click here
Editor-in-Chief: Cheng Kam-ling
Follow the latest financial news analysis, like hket Facebook
Subscribe to the Hong Kong Economic Times email newsletter
Receive first-hand financial news Learn more about investment and financial knowledge Submit my consent to receive promotional messages from Hong Kong Economic Times Group. You may also check the privacy policy of this website Terms of Use

"The United States is experiencing a severe shortage of medicines and drugs, with a 30% increase in shortages last year compared to 2021."

Title:

Content: The New York Times Original
Continue reading Growing drug shortage in the United States has become a threat to national security
The shortage of medicines in the United States last year increased compared to 2021 by 30%, according to The New York Times.
However, the article notes that the growing shortage of inexpensive but critical drugs poses a national security threat to the United States.
The growing shortage of inexpensive but critical drugs poses a threat to U.S. national security and forces hospitals to make “terrible ” choices, writes The New York Times, citing a report prepared for hearings in the U.S. Senate.
According to this report, the shortage of medicines last year increased by almost 30% compared to 2021, with an average shortage of medicines observed for 18 months, and for some drugs – 15 years.
Among the drugs in short supply are conventional antibiotics and anesthetics, the article said.
Senator Gary Peters, a Democrat from Michigan and chairman of the Senate Committee on Homeland Security and Government Affairs, said that these problems are related to economic factors, an opaque supply chain and the fact that 80% to 90% of some products are made abroad.
“Taken together, these underlying causes not only raise serious concerns about ensuring proper patient care, but also pose a serious threat to national security, ” Peters said.
Dr. Andrew Schumann, an oncology surgeon from Michigan, told senators at the hearing that the shortage of drugs in his field is "a tragedy occurring in slow motion."
As Schumann noted, recently due to the shortage of one cheap, but well-proven cancer drug, he had to choose which patients will receive this drug.
The article notes that many of the cheapest drugs tend to be made in countries such as India and China, where they are inexpensive to manufacture.
However, this concentration of production capacity creates an additional level of vulnerability to problems such as natural disasters and political unrest, emphasizes The New York Times.
The materials of InoTV contain estimates of exclusively foreign media and do not reflect the position of RT
We publish on Twitter relevant foreign articles selected by the editorial office of InoTV
source
New York Times United States of America
tags
disease india china medicine usa
Today in the media
Popular
INFOX.SG
RT News Feed
Partners news

Taiwan is experiencing a medication shortage, with 131 medicines out of stock, including common medications like amoxicillin and acetaminophen.

Medications such as magnesium oxide, Ammonicillin, and acetaminophen painkillers are still in short supply in Taiwan, posing a risk to first-line medical care.

Carboplatin and cisplatin, used in cancer treatments, have been in short supply, with 93% and 70% of treatment centers reporting shortages, respectively.

Title:

Content: |

FTC, US Health Dept Launch Probe Over Chemo Drug Shortages

The investigation is targeting so-called middlemen that broker deals between hospitals and pharmaceutical companies.

Sign up for smart news, insights, and analysis on the biggest financial stories of the day.

Each year, roughly 2 million Americans are diagnosed with cancer, and for some, getting the proper treatment has become a very serious waiting game.

This week, the Federal Trade Commission and the US Department of Health jointly launched a probe seeking information on how middlemen — group purchasing organizations (GPOs) and drug wholesalers — may be contributing to a lack of chemotherapies and other generic drugs.

The Cost of Cheap Drugs

While various cancer treatments have gone in and out of short supply for years, the problem became particularly acute in 2023. In May, a survey from the National Comprehensive Cancer Network found that 93% of treatment centers reported they were short on carboplatin and 70% reported they were short on cisplatin. Those two drugs are used together and are prescribed to 10% to 20% of cancer patients. Those shortage rates dropped in the fall, but still sat at uncomfortably high levels, with many patients experiencing longer wait times between chemo sessions.

Access to raw materials for making drugs and an increase in patients play a part in the shortages, but the FTC and the Health Department suspect the middlemen buying and selling the medications might be at the heart of the issue:

  • Hospital transactions for medications are controlled almost entirely by three GPOs — Vizient, Premier, and HealthTrust — that purchase drugs on behalf of health centers, and three wholesalers — AmerisourceBergen, Cardinal Health and McKesson — that supply 90% of the pharmaceuticals, The Wall Street Journal reported.
  • Doctors, drugmakers, and patient advocate groups have argued that because the three GPOs represent so many hospitals, they’re able to win extremely low prices from wholesalers. But the prices may be so low that some drugmakers slash production or stop making the drugs entirely if they feel they can no longer turn a profit.

“For years Americans have faced acute shortages of critical drugs, from chemotherapy to antibiotics, endangering patients,” said FTC Chair Lina Khan. “Our inquiry requests information on the factors driving these shortages and scrutinizes the practices of opaque drug middlemen.”

A Growing Concern: A short supply of cancer treatments isn’t a great development, especially with new evidence that the disease is on the rise among younger generations. Most cancer patients are 65 and older, but one study published in JAMA last summer found cancer rates among people 50 and younger are going up, mostly driven by women and people in their 30s.

One of the challenges in the healthcare system is the unfair pricing mechanism, which makes medicine inaccessible to many people, particularly those not participating in the health insurance system.

Title:

Content: Crowding citizens in front of the ambulance pharmacy reveals the extent of suffering …
6.
The suffering of poor patients is due to the lack of medicines.
Where the pharmaceutical market has been suffering for several consecutive months from a severe shortage in many varieties.. Which prompted citizens to crowd in front of the ambulance pharmacy in long queues to buy those shortcomings after they disappeared from all pharmacies..
Hustle...
Chaos...
Hundreds of men and women crowded in long queues that extend for several hours.. This is the scene in front of the ambulance pharmacy in the center of the country. People with chronic diseases of sugar, pressure, heart, nerves and colon became their only hope to find essential drugs for them in the pharmacy.. The absence of these drugs does not only expose them to more pain but may expose them to death.. They can not do without them..
The drug shortage crisis.
It is not a new crisis, but it has been repeated many times during the previous term of Minister “Khaled Abdel Ghaffar ”.. Instead of trying to solve the crisis, the government is going against the trend, where the Deputy Prime Minister and Minister of Health Dr.“ Khaled Abdel Ghaffar ” in statements after the government statement to parliament to the need to increase the prices of medicine in Egypt because it is the cheapest in the world and sold abroad by 50 times. According to the data of the Medbelle global platform for health care and funded by the European Fund for Regional Development in 2021, Egypt is ranked ninth in the list of cheapest countries in the world in the sale of medicine, and did not come in the first place as mentioned by the minister
Despite the repeated statements of the Prime Minister and the Minister of Health to resolve the crisis and provide the missing medicines, and despite the government ’ s repeated talk about the localization of the pharmaceutical industry in Egypt, the reality is quite the opposite.
There are a number of terrible complaints about the lack of medicine in public hospitals and pharmacies, including a collective complaint from the patients of the university hospitals in Assiut Governorate of the lack of availability of drugs and the absence of dye injections, which puts their lives at risk. Although the patients filed a complaint to the governor two weeks ago, but to no avail. The long queue of two or three hours to win a box of insulin Maxtard despite the increase in the price from 60 pounds to 93 pounds confirms the extent of suffering experienced by patients. Also, the disappearance of Indoxan injections used in chemotherapy sessions threatens oncology patients, where thousands of patients in oncology institutes and hospitals suffer from delayed chemotherapy sessions for lack and disappearance of Indoxan injection. The right to medicine, but the crisis still exists.
There is also a shortage of many drugs, including blood thinners and clots solvents, drugs for the treatment of cancerous tumors, multiple sclerosis drugs, drugs for the treatment of liver diseases, drugs for stomach ulcers and blood pressure, drugs for sinuses, heart and thyroid diseases, dozens of types of analgesics, antibiotics and vitamins, as well as anesthetics used in anesthesia and solutions in public hospitals. Subsidized children, which was exploited by the mafia of the black market to raise prices to double the original price of milk can up to 500 pounds..
All types of treatments for epilepsy, depression, obsessive-compulsive disorder, phobias and hyperactivity disease are still unavailable due to the lack of import of raw materials.
Health Insurance Patients
The crisis is not limited to hospitals and pharmacies only, but the branches of health insurance suffer from a large shortage of medicine and also medical supplies, which led to the closure of the operating rooms in the branches of insurance in the province of Beni Suef..
In the health insurance clinics in Cairo and Giza, many of those who frequent these clinics complained that they come from 7 am to reserve their roles in order to dispense their medicines and end up sitting in the pharmacy waiting for the pharmacist who dispenses them some of them, and the rest of their medicines are separated in new prescriptions to be dispensed from the insurance pharmacies, if any. Blood thinners and thrombotic solvents, some pressure medications, multiple sclerosis medications, stomach ulcer and thyroid medications, sugar, antibiotics, vitamins, Parkinson ’ s medications, and hyperactivity protocol.
Many cases complained of the lack of their medicines, which they have been dispensing for years.. And they were dispensed periodically every two months for a year after the approval of the Drug Committee to dispense those medicines, including a special medicine liquidity imported medicines, and patients with diabetes and blood diseases were their complaint that any imported medicine and its price expensive requires the highest approval of a committee in the Council of Ministers..
Although patients have been dispensing the same medication for several years, this complaint is frequent from universal health insurance patients.
Detention of raw materials
Dr. Ali Auf, head of the pharmaceutical division of the Federation of Chambers of Commerce, said that the reason for the worsening of the shortage of medicines is the detention of raw materials in ports, pointing out that there are about 1000 items that are not available.
Exchange rate
Mahmoud Fouad, Executive Director of the Right to Medicine Association, said that the aggravation of the crisis is due to the companies stockpiling medicines in anticipation of higher prices, explaining that the crisis began about two years ago due to the shortage of raw materials as a result of the high exchange rate and the inability of companies to provide dollar materials to import raw materials.
Fouad stressed that there are more than 1000 drugs whose prices rose during the past year by rates ranging from 25% to 60%, pointing out that the increase reached during the current days to 60% for the local and 80% for the importer.
Fouad described the statements of the Minister of Health about the price of Egyptian medicine as being 50 times lower than abroad as shocking, pointing out that there was a successive movement of prices from the Drug Pricing Committee of the Egyptian Drug Authority starting in 2023, which resulted in the movement of about 1,000 varieties.
He explained that Egypt suffered during the last two years from the phenomenon of medicine shortage due to the shortage of imported raw materials as a result of the economic crisis and the fluctuation of the exchange rate … and the crisis affected items considered life-saving.
Fouad stressed that drug sales in Egypt reached about $3 billion a year in 2023 without the sales of the armed forces and the interior and tenders of the Ministry of Health, which means that Egypt is considered the largest market in the region.
Unfair pricing system
He explained that Egypt had been subject to the pricing of medicines for 10 years according to the decision of the Minister of Health under the system of "lower pricing for neighboring countries" and then the pricing was according to the decision 413 of 1991, which is "calculating the cost and profit margin for companies and distribution and then pharmacies" according to the compulsory pricing that began in 1988.
He explained that the pricing is according to the cheapest price in the reference countries identified by the World Health Organization (WHO) in 36 countries to guide their prices and the minister to take them or not, pointing out that these countries are the major industrial countries and have comprehensive health insurance laws, which Egypt lacks.
Fouad added that this system in pricing is unfair as medicine has become subject to market mechanisms, supply and demand and suspicions of monopoly, the price is controlled by the policy of supply and demand, which makes medicine a commodity sold to those who can, especially since there are more than millions of Egyptian people not participating in the health insurance system, which only 63% of citizens participate.
Fouad pointed out that Egypt has about 17 officially registered medicines, 90% of which are manufactured, 176 companies that own factories, 7 business sector companies, 22 branches of foreign companies and 1,200 commercial companies that do not own a factory.
He stressed that the crisis of medicine shortage and successive rises will make the Egyptian citizen groaning and unable to bear it.
Fouad warned of the danger of the expected increases in drug prices during the coming period.

One of the challenges in the healthcare system is a significant shortage of nurses.

Title:

Content: Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most effective drug to give patients who are in post-operation pain - but staff at one hospital trust in particular have been told to pull the plug on the drug from anaesthetic rooms immediately.

The shortage of IV paracetamol is expected to run into November at earliest, with a Department for Health and Social Care spokesman blaming 'capacity constraints with a manufacturer' as the cause. One hospital worker detailed how deeply worried they were at the shortage - citing how it is much more effective than the orally consumed version.

They said: "It is deeply worrying. We use IV paracetamol because tablets taken orally are only 30% effective. Given by IV it is a potent and direct drug and it restricts pain very quickly."

Read more: Doctor warns that silent pandemic 'scarier' than Covid-19 is already killing a million a year

It is reported by The Mirror that they went on: "The alternatives are oral morphine, which is very slow-acting, or nonsteroidal anti-inflammatories such as ibuprofen and aspirin, which can have negative side effects such as bleeding and allergic reactions."

Drug shortages have become a global problem, worsened by the recent Covid pandemic, the ongoing war in Ukraine, the energy crisis and record levels of inflation. Last winter, France completely culled the internet sales of paracetamol products in a widespread shortage blamed on a Chinese export ban on raw materials.

In Great Britain meanwhile, it is Brexit which is primarily blamed for making matters worse. This is because drug imports from the EU - which historically make up two thirds of the National Health Service's supply - are at their lowest ever levels since leaving.

The health department’s spokesman, said: "Guidance has been issued to the NHS advising on how to manage the issue and we are working with those in the supply chain to resolve this as soon as possible."

Labour’s shadow health minister, Liz Kendall, said: "Concerned staff and patients will understandably be seeking reassurance that the pain relief they need is available. The Government must spell out the urgent steps being taken to resolve the shortage."

It comes after a Covid Inquiry heard that a lack of nurses left the NHS and Great Britain vulnerable to the pandemic - with the infection control lead at the Royal College of Nursing telling of a national shortage of PPE due to a lack of planning for an airborne virus.

Rosemary Gallagher, the RCN’s professional lead for infection prevention and control, explained: "The resilience of the health and care workforce is absolutely essential in order to be able to deliver health care services that meet the public's needs. We know that we went into the pandemic with a significant shortage, about 50,000 nurses short.

"That immediately put us at risk when we needed to surge capacity to support patients at home and in hospitals."

The intervention came the same day that a damning international study warned that Britain has fewer nurses than other developed nations.

The healthcare system is facing challenges such as supply chain disruptions and staff vacancies, which can impact the availability of medications.

"Cancer medications, including cisplatin and carboplatin, are among the types of medications affected by shortages, with over a dozen cancer drugs experiencing shortages in recent months."

Title:

Content: As drug shortage list grows, many hospitals face tough decisions on rationing care

More than half of hospital pharmacists are reporting a critical shortage of chemotherapy drugs and nearly all are reporting overall medicine supply gaps as prescription drug shortages near an all time high, according to a new survey.

Hospital pharmacists said drug shortages have forced 1 in 3 health systems to delay, cancel or ration care or switch to alternate drugs to continue to treat patients. And 99% are reporting some drug supply shortages, an American Society of Health-System Pharmacists survey of more than 1,000 pharmacists released Thursday found.

The organization reported shortages of 309 drugs, near the all-time high of 320 shortages in 2014. The scarcity of key drugs is prompting hospitals to find or substitute drugs and change treatment plans as needed.

“In some cases, there are no alternatives to the affected drugs, which puts patients at risk," ASHP Chief Executive Officer Paul W. Abramowitz said in a statement. "This issue requires quick action from Congress to address the underlying causes of shortages and ensure patients have the medications they need.”

Cancer drug shortages

In June, the Food and Drug Administration said it will temporarily allow overseas drug manufacturers to import some chemotherapy drugs.

The FDA allowed Qilu Pharmaceutical, a drug manufacturer in China, to import the injectable chemotherapy drug cisplatin in 50-milligram vials. Toronto pharmaceutical company Apotex Corp. will distribute the medication in the United States.

More than a dozen cancer drugs have been in shortage in recent months, including cisplatin and carboplatin, used to treat lung, breast, prostate and gynecologic cancers. The National Cancer Institute said cisplatin and similar drugs are prescribed for 10% to 20% of all cancer patients.

In June, the National Comprehensive Cancer Network released a survey of 27 academic cancer centers that found 93% reported shortages of carboplatin and 70% faced shortages of cisplatin.

When cancer hospitals face such shortages, they attempt to make sure there's enough medication for patients to finish the course of treatment, said Mike Ganio, ASHP's senior director of pharmacy practice and quality.

Cancer hospitals facing such shortages might change medications for new patients starting on chemotherapy, said Ganio, a former pharmacy manager at an academic cancer center.

"You try to keep that patient on the same regimen as much as you can, unless they're failing it for some reason, and then you would switch," Ganio said.

Steroids, hormonal drugs also in short supply

More than 1 in 5 hospital pharmacists also reported shortages for steroids, hormonal drugs and oral liquids such as lidocaine, ibuprofen and amoxicillin.

A smaller number of pharmacists said heart medications, emergency prefilled syringes and drugs used for intensive care unit patients were in short supply. Others reported shortages of attention deficit hyperactivity disorder medicines, antimicrobial drugs and injectable opioids.

In all, about two-thirds of pharmacists said the shortages were "moderately impactful," which means they are managing shortages but patients are affected.

Pharmacists are managing the shortages by offering therapeutic alternatives, buying different vial sizes or concentrations and rationing medicines.

This article originally appeared on USA TODAY: Survey: Drug shortages are widespread, hospitals ration care

Medications affected by shortages include carboplatin, cisplatin, steroids, hormonal drugs, and oral liquids such as lidocaine, ibuprofen, and amoxicillin.

"The medication shortage affects over 135 drugs, including chemotherapy drugs for cancer, as reported by the FDA."

"Medications such as amoxicillin, acetaminophen, magnesium oxide, and ibuprofen are affected by shortages, with a total of 131 medicines out of stock in Taiwan."

Medication shortages affect all drug classes, with the most concerning being sterile injectable generic drugs, including cancer chemotherapy and emergency drugs.

Title:

Content: General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
An Unexpected Catastrophe in the World ’ s Largest Country: The Complete Story of U.S. Drug Shortages
The deficit is at a record level.
According to data from the American Society of Health System Pharmacists and the University of Utah Drug Information Service, organizations began tracking drug shortages for the first time in 2001. Steady since 2021 – now reaching a record high of 323 drugs in the first three months of 2024.
Paul Abramowitz, CEO of the American Society of Health System Pharmacists, wrote in a blog post on Thursday: “It ’ s been a long time to end drug shortages, ” and wrote:“ All drug classes are vulnerable to shortages, some of the most worrisome shortages include sterile injectable generic drugs, including cancer chemotherapy drugs and emergency drugs stored in hospital vans and procedural areas. It is dangerous for doctors and patients. ”
In addition to the 32 chemotherapy drugs that are deficient, the five categories of drugs with the greatest deficiency include central nervous system stimulants, antimicrobials, hormonal agents, and intravenous fluids. [1] The Drug Deficiency Database maintained by the American Society of Health System Pharmacists and the University of Utah is based on voluntary reports from practitioners, patients, and others that have been confirmed by manufacturers. The U.S. drug is in short supply, because it captures broader effects on service providers and patients.
The crisis has lasted a year and a half.
More than half of the treatment shortages have lasted for more than two years, according to an analysis by health consultancy IQVIA, and the average shortage affects at least half a million patients, many of them elderly, according to the US Office of Health and Human Services under the Assistant Secretary for Planning and Evaluation, which shared its analysis with Congress in May.
Growing demand can play a role in drug shortages, as with the recent shortage of weight-loss drugs, but often manufacturing and quality problems, such as supply chain gaps and downtime, are the root cause. And varied.
But the American Society of Health System Pharmacists has “serious concerns ” about parts of this proposal, especially financial sanctions imposed on hospitals that lack the resources to comply with the recommendations, Abramowitz wrote:“ We all know that managing shortages is not enough and is not a sustainable solution to the worsening crisis, and there is still a lot of work to be done at the federal level to fix the root causes of drug shortages. ”
Why Shortage Occurs
Shortages can be caused by high demand, as with the recent shortage of weight-loss drugs, but this is not usually the main problem.
The FDA also blames manufacturing and quality problems, supply chain gaps, and downtime, and Dr. Emily Tucker, a drug shortage expert and an assistant professor of industrial engineering at Clemson University, says that when there is an indication of shortages, large health systems often also proactively place large orders, adding to the system ’ s stress.
“I don ’ t blame anyone.
“When I talk to all the stakeholders – whether it ’ s wholesalers, manufacturers, or the government – everyone wants this problem to end, ” she said.
Lack of transparency
Dr. Julie Grallo, chief medical officer and executive vice president of the American Society of Clinical Oncology, told the House Committee earlier that the shortage puts providers in a terrible position: “The drug shortage crisis is forcing providers to make impossible choices, and it is also hindering the development of new drugs. Health drugs are purchased only on a price basis, and manufacturers do not have to disclose the source of their acquisition of the ingredients.
The shortage of this generic chemical drug came due to the closure of one factory in India that manufactures the active ingredient after a surprise FDA inspection found “significant quality issues, ” says Jarallo:“ We didn ’ t know, and there was no transparency regarding the company ’ s supply of the majority of active pharmaceutical ingredients to all manufacturers across the board.
Knowing this in advance, we could have responded much faster, ” Dr. Steven Schundlemeyer, director of the PRIME Institute of the University of Minnesota School of Pharmacy, which focuses on economic and management issues, told the committee that as with defense contractors in the United States, New Zealand requires manufacturers to disclose their suppliers, and that information is required.
Easily accessible in the database.
Related Topics

The supply of pharmaceuticals has been affected by several factors, including the Covid pandemic, the war in Ukraine, the energy crisis, inflation, and Brexit, which have contributed to global drug shortages.

The supply of pharmaceuticals has been affected by factors such as the Ukrainian war, which caused supply gaps, and changes in manufacturing decisions when pharmaceutical companies change ownership.

Title:

Content: Doctors worry, but Medicines Agency says drug crisis is unlikely

Estonian pediatricians, general practitioners, and infectious disease organizations have written to Health Minister Riina Sikkut (SDE) to voice their concern over a lack of adequate antibiotics for small children, especially with autumn approaching.

In the spring and summer of this year, patients, physicians and pharmacies were all faced with a shortage of a number of first-line and pediatric medications.

"The issue began last fall, when there were serious concerns regarding the availability of antibiotics for both adults and children. Concerns regarding antibiotics for adults waned by the end of the year, but concerns about antibiotics for children persisted until midsummer. Eight out of 10 antibiotics are now available," Marko Tiisler, head of the agency's imports and exports monitoring department, said.

An experienced pharmacist, Kai Kimmel, said that although the current situation is favorable and medicines are readily available, the dread of supply shortages remains.

"Supply issues are not solely the responsibility of importers, but also of manufacturers. When the Ukrainian war began, there were so many supply gaps that we had a genuine difficulty — there were some active components that were entirely out of reach. Then there's also a scenario where one pharmaceutical company is sold to another, and the new manufacturer decides that it's no longer necessary to make all of the (medicines) that the old one did," Kimmel went on to say.

On the pharmaceutical market there is always a concern about a lack of certain medications.

"Meanwhile, we're like gamblers, checking the wholesaler's sales portfolio every now and then to see whether there's a shortfall. If there is a shortfall," Kimmel said. "And so it's been all summer like that with the children's antibiotics and a few more prescription drugs, but things are looking better for the time being."

"If a drug hasn't been available for a long time and then appears in a wholesale warehouse, everyone rushes to buy it; pharmacies scramble to be the first to get it, while the rest miss out," he added.

"The European Medicines Agency (EMA) has inquired about pharmaceutical companies' projections for the coming season. We have also examined ourselves the consumption in recent years ans the demand for medicines in Estonia. We are confident that there are now no major concerns at the moment; medicine supply will meet demand," Tiisler said.

--

Follow ERR News on Facebook and Twitter and never miss an update!

Editor: Marko Tooming, Kristina Kersa

Hea lugeja, näeme et kasutate vanemat brauseri versiooni või vähelevinud brauserit.

Parema ja terviklikuma kasutajakogemuse tagamiseks soovitame alla laadida uusim versioon mõnest meie toetatud brauserist:

"The COVID-19 pandemic has caused delayed production by major manufacturers, leading to a shortage of pharmaceuticals, including Adderall. Pharmaceutical companies are reluctant to disclose the cause of the drug supply shortage."

The supply of pharmaceuticals has been affected by the coronavirus pandemic, leading to shortages of certain medicines, including antipyretic drugs, in countries like China, Singapore, and Hong Kong.

Title:

Content: Putin between the flames of withdrawal and the continuation of the war..
"Drug shortages" threaten China's health
The most prominent international newspapers on Saturday morning dealt with the latest developments of the Ukrainian war, amid reports that Russian President Vladimir Putin can not retreat from the conflict because the decision may threaten his "personal survival", despite the setbacks suffered by his forces on the battlefields.
This comes as newspapers reported that Ukrainian forces are "armed" with artificial intelligence to outperform their Russian counterparts.
In China, newspapers have highlighted the country ’ s “medicine shortage ” crisis that could threaten the health situation there.
Putin is stuck between two fires
A retired U.S. general told Newsweek that Putin is now in a position where he can ’ t make significant gains in his war in Ukraine, but he also can ’ t back down from the conflict because his “personal survival ” is at stake.
Barry McCaffrey said the Russian leader had "already lost the military trick" in Ukraine, including achieving strategic goals such as seizing the Ukrainian capital, Kiev, and the entire Black Sea coast, including the port city of Odessa.
Putin is now in a position where he cannot make significant gains in his war in Ukraine, but he also cannot back down from the conflict because his “personal survival ” is at stake.
A retired American general.
Yuri Zhukov, a political science professor at the University of Michigan, gave a somewhat similar assessment to McCaffrey, but stressed that Putin ’ s current inability to achieve key goals “may change in the future. ”
Gokum told the magazine that if Russia launches another offensive to take control of Kiev in the spring of 2023, it is unlikely to end successfully, but he saw the move as having a military advantage over forcing Ukraine to divert resources from other parts of the conflict to defend Kiev, creating opportunities for Russia to make potential advances in the south and east.
A similar situation is already happening, Zhukov said, with Russia launching waves of strikes against Ukraine ’ s critical infrastructure, forcing the war-torn country to choose between supporting its military effort or defending civilian centers.
Zhukov added: “Putin is playing a long game.
Having failed to deliver a decisive knockout blow in the first phase of the war, he is betting that a protracted conflict will serve Russia ’ s interest.
Putin is playing a long game.
Having failed to deliver a decisive knockout blow in the first phase of the war, he is betting that a protracted conflict will serve Russia ’ s interest.
Yuri Zhukov, Professor of Political Science at the University of Michigan
"This is not an illogical assumption, because a long war will require continued and escalating Western military assistance, and political support for such assistance is waning in Europe and the United States," he said.
The source pointed to negative reactions by some members of Congress to the visit of Ukrainian President Volodymyr Zelensky to Washington on Wednesday.
Zhukov noted that if Ukraine is unable to offset its losses with new equipment and resources from the West, the continued attrition from Russia ’ s attacks will eventually lead to an increase in its losses, “making it difficult for Ukraine to hold territory, let alone liberate territories already occupied by the Russians. ”
Zhukov said it is this strategy that Putin seeks to achieve a tangible victory on the battlefields.
"Putin does not need to retreat or take control of Kiev.
He just needs to keep up the pressure and wait for the collapse of Western support for Ukraine. ”
On Friday, the U.S. House of Representatives passed a $1.7 trillion spending bill that includes $45 billion in additional aid to Ukraine.
It remains unclear how Republicans, some of whom oppose sending more money to Ukraine and who will take control of the House early next year, could play a role in opposing any future attempts to provide aid to Kiev.
If Ukraine is unable to offset its losses with new equipment and resources from the West, continued attrition from Russia ’ s attacks will ultimately increase its losses.
Artificial intelligence.
Ukraine's weapon to encircle the Russians
The British newspaper "The Times" reported that Ukrainian forces managed to encircle their Russian counterpart, as Kiev turned to technology companies to use its artificial intelligence to cope with the "modern conflict".
The Times said in a report published today on its website that Ukrainian soldiers have “revolutionized ” the way battles are fought in the 21st century by waging“ algorithmic warfare ” that enables them to outperform Russian invaders with far fewer troops.
Military experts told the British newspaper that advanced technology in the world of artificial intelligence developed by companies in the West gave Ukraine a technological advantage over Russia, turning the tide of the war.
Although conventional artillery still dominates the war, the accuracy, speed and gravity of Ukrainian strikes have increased dramatically thanks to software developed by U.S. technology firm Palantir.
Ukrainian soldiers have "revolutionized" the way battles are fought in the 21st century by waging an "algorithm war" that enables them to outperform Russian invaders with far fewer troops.
The Times.
"The Russians are using their artillery as if it were World War I, but what the Ukrainians are doing is completely different.
It's a digital army fighting an analog army.
What you see is that the digital army, though small, is able to vastly outperform its analog adversary. ”
The newspaper pointed out that Blantyre is closely linked to the US Central Intelligence Agency (CIA).
I.A., which was one of the first investors, has opened an office in Kiev.
The company ’ s artificial intelligence program, which operates in Ukraine, relies on intelligence gathered around enemy forces ’ positions by commercial satellites, heat sensors and reconnaissance drones as well as spies working behind enemy lines.
The AI program is being used to turn data into a map that highlights the potential locations of Russian artillery, tanks and troops.
"A Ukrainian soldier using a tablet is given a list of coordinates and can then direct his fire."
Alex Karp, chief executive of Planter, said: “The power of advanced algorithmic warfare systems is so great that it is equivalent to having tactical nuclear weapons against an adversary with conventional weapons only. ”
According to the company ’ s report, ethical concerns have been raised about AI ’ s ability to sift information in peacetime as well as war.
Planter has built a controversial reputation for its tendency to make governments rely on its products in areas such as healthcare, while privacy campaigners have raised concerns about its power.
In 2019, its technology was used to track illegal immigrants in the United States.
The power of advanced algorithmic warfare systems is so great that it is equivalent to having tactical nuclear weapons against an adversary with conventional weapons only.
Alex Karp, CEO of Planter
"Drug shortage" threatens health situation in China
On the other hand, the American newspaper "Wall Street Journal" reported that the crisis of "medicine scarcity" suffered by China as a result of the spread of the coronavirus, threatens the health situation in the country, which made pharmacies struggling to store necessary drugs during the pandemic.
Pharmacies across China have reported shortages of antipyretic drugs, including ibuprofen, paracetamol and other fever drugs, as the country struggles to cope with an increase in coronavirus cases, weeks after Beijing abandoned its strict zero-covid policy.
Chinese officials denied there was a shortage of medicines or medical equipment and ignored offers of assistance from the United States to supply vaccines and other medical goods.
The shortage of medicines in China has also spread to Singapore and Hong Kong, as anxious relatives scrambled to send the medicines home.
The Wall Street Journal made phone calls to pharmacies in nine Chinese provinces, including Shanghai, Fujian, Hubei, Sichuan, Qinghai, Guangdong, Guangxi, Anhui and Zhejiang, all of whom said they lacked fever medicines and cold treatments.
Chinese officials denied there was a shortage of medicines or medical equipment and ignored offers of assistance from the United States to supply vaccines and other medical goods.
A doctor named Zhang, who works at a public hospital in Ningling District in central China's Henan Province, was quoted as saying the hospital was "selling" fever medicines to patients.
He added that local authorities were concerned about storage and price manipulation, explaining that even their hospital stocks were less than adequate.
A Shanghai resident told the newspaper that he had noticed a marked shortage of drugs such as ibuprofen.
He said he was just getting over his coronavirus himself, and that he was able to recover quickly thanks to the antiviral drugs he bought during his trip to another country.
The source added that the lack of guidance from authorities on the spread of the virus or what to do about ordinary citizens and sick employees, is a contradiction from earlier in the year, when the local government set strict operating conditions for companies wishing to stay open.
In the near term, China may face another bout of turmoil caused by the coronavirus, with worker and employee infections on the rise.
Wall Street Journal
In the near term, China could face another bout of turmoil caused by the coronavirus, with worker and employee infections on the rise.
Even with a less lethal strain of the virus, she said, the lack of exposure to the virus over the past three years means Chinese lack so-called "hybrid immunity" that leads to less severe symptoms and lower mortality rates.
Health experts say hybrid immunity comes from a combination of exposure to the virus and vaccination, saying it provides a stronger and longer lasting defence against the virus.
With almost no exposure to the disease, China relies on a vaccination program to ward off the virus, they said.
They warned that the protection offered by vaccination would diminish within a few months.
The lack of exposure to the virus over the past three years means that the Chinese lack so-called “hybrid immunity ” that leads to less severe symptoms and lower mortality rates.
Most Read
No stories found.
Erm News
www.eremnews.com

Cancer medications, including cisplatin and carboplatin, are among those affected by the shortage in the US, posing risks to patients with lung, breast, prostate, and gynecologic cancers.

"The US is experiencing a shortage of over 135 drugs, including chemotherapy and ADHD medications."

The medication shortage in the US affects various drug classes, with sterile injectable generic drugs, such as cancer chemotherapy and emergency drugs, being particularly impacted.

"The medication shortage in the US affects various types, including chemotherapy drugs, central nervous system stimulants, antimicrobials, hormonal agents, and intravenous fluids."

"The US is experiencing a shortage of 323 medical drugs, including general injection disinfection drugs, cancer chemotherapy drugs, and emergency medicine stores, affecting various types of medications."

Generic medicines are available as an alternative to brand-name medications in case of supply issues.

The text mentions generic drugs as an alternative to brand-name medications, specifically highlighting Teva, the world's largest generic drug manufacturer, and its decision to reduce production of some generic drugs.

Medications such as oral morphine, ibuprofen, aspirin, and paracetamol have been affected by shortages, with France experiencing a shortage of paracetamol products and Great Britain facing low drug imports from the EU.

Government price controls, which slashed the price of drugs, led to a shortage of medications as local pharmaceutical companies became less willing to produce low-cost drugs.

Government price controls may be contributing to medication shortages in Egypt, as manufacturers struggle to produce medicines at low enough costs to be profitable.

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
I'm sorry.
My grandfather, Zainuddin.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
I'm sorry.
My grandfather, Zainuddin.
Smuggling burns drug stability
Libya and Sudan are the main destinations.
And the profits are huge.
Deficiencies include stents, heart medications, diabetes, pressure, and tumors.
It is an undeniable fact that the Egyptian pharmaceutical market is experiencing a crisis of shortage of some vital items on which citizens depend mainly, and at all levels, which exacerbated the suffering of patients in public hospitals affiliated to the government, which receive subsidized medicines at low prices, so that the so-called alternative class becomes a citizen ’ s refuge, to get the necessary dose of medicine, to alleviate his health suffering or save his life.
At a time when it is assumed that more than 90% of medicines are manufactured in Egypt, citizens' complaints about the lack of many medicines and medical supplies in the markets and hospitals are escalating to the extent that deputies submitted a number of requests for briefing through the deputies, stressing that the crisis lies in the raw material itself and imported in dollars.
And the pressure.
Thyroid and sugar.
The main reasons lie in the importation of 95% of raw materials in addition to the presence of “smuggling brokers ” whose mission is to smuggle Egyptian medicine to neighboring conflict countries, especially Libya and Sudan, in order to sell it abroad at exorbitant prices, and to reap huge profits, according to some pharmacists and specialists. In addition to Sudan ’ s import of Egyptian medicine in hard currency, especially with the licenses of Egyptian medicine compared to others and the stopping of factories in neighboring countries because of their conflicts.
According to Ali Abdullah, head of the Egyptian Society for Pharmaceutical Studies (an NGO), the lack of medicines and their disappearance from the local market is a real crisis in case of smuggling, such as insulin, tumors, anesthesia, surgical supplies, serums and vaccines.
The shortage of hard currency in Egypt is also one of the reasons for the disappearance of medicines.
Mahfouz Ramzi, head of the Pharmaceutical Manufacturing Committee at the Cairo Pharmacists Syndicate, pointed out that there are organized gangs that smuggle medicine to countries of conflicts and wars, explaining that “most operations are conducted through land border roads, and the Egyptian Drug Authority is responsible for inspecting companies, factories and any pharmaceutical institution, to ensure that medicines produced in Egypt are in the normal sequence until they reach pharmacies. ”“ Some smuggling professionals deal with drug stores, where they buy large quantities of medicines, take advantage of discounts on them, and then smuggle them abroad to take advantage of the price difference. ”
The Executive Director of the Egyptian Center for the Right to Medicine, Mahmoud Fouad, confirmed that "the drug stores have turned into an illegal business and a back gate for drug smuggling and expired drug trade, as most of them are not licensed and sold without invoices, and are not subject to the umbrella of the Ministry of Health, in addition to the lack of health standards required to practice the profession of pharmacy, after some stores are run from apartments away from the eyes of the Ministry of the control bodies. 90% of its owners are not pharmacists. ”
“Are these stores registered with the Ministry of Health?
And are they subject to pharmaceutical inspection or from the Drug Control and Research Authority? ”, stressing that most of the small pharmacies in the villages “do not have the ability to buy medicine from distribution companies, which makes them resort to buying from stores after agreeing on specific facilities and periods for payment, ” pointing out that“ popular medicines in Egypt are the most smuggled abroad. ” From 250 pounds ($8 at the official exchange rate).
According to Dr. Ashraf Hatem, Chairman of the Health Committee in Parliament, it is a social responsibility, and priorities must be set, and all parties sitting together may help to solve the crisis, in light of the apparent shortage of a number of medical drugs, and his demand that the Drug Authority publish periodically and daily alternatives to the missing medicines in the absence of the original medicine. In addition, the pharmaceutical industry continues to operate and produce.
For all this and for the continuation of the crisis of drug shortage it was necessary to search and investigate the causes and solutions!
During the meeting of Gamal al-Laith, Chairman of the Chamber of Pharmaceutical Industry at the Federation of Industries, in the presence of Minister of Health Dr. Khaled Abdel Ghaffar, the Governor of the Central Bank, Hassan Abdullah, and others, he sent letters of reassurance to the Egyptian people about the existence of a solution to pump the needs of the market of foreign currency to end the shortage of medicines. Or psychologically for the patient.
He said: « The medicines that suffer from the shortage, some of them are sugar drugs and other drugs tumors and drugs of the glands and heart, drugs related to chronic diseases, which is now being secured, and we as factories work with a stock of raw materials enough for 4-6 months, and this stock reached only weeks, and therefore we are now in the stage of risk, and therefore the government began to move ».
He added that the health sector is supported by the provision of foreign exchange resources to provide all needs according to a plan to deal with such circumstances, stressing the importance of full coordination between the unified purchasing authority and the pharmaceutical industry room as well as pharmaceutical companies to face any problems related to the shortage of supplies, medicines and medical consumables.
As well as a detailed presentation on the commitments implemented and not implemented in the period from June 2023 to January 2024, with regard to the provision of (medicines, medical supplies, laboratory supplies, devices, raw materials and packing materials), and the Minister was briefed on the results of the mechanisms established with the Central Bank of Egypt to pay the obligations in foreign currency to meet the demands of the health care sector.
In the end, the official spokesman stressed that the shortage of drugs does not exceed 15% and the drugs directed to tumors are at the forefront of the shortcomings because of their close link to the currency and what faces the supply chains, otherwise all drugs and within them are compatible... The complaints are due in their entirety to the lack of knowledge of citizens with the trade names of medicines.
In addition to the above, a severe shortage of anesthetic drugs, dental pening drugs, nephrology and recovery drugs, which will cause a real disaster that threatens the conduct of surgical operations for patients, and thus increase the waiting lists in hospitals and the occurrence of complications for patients that may result in loss of their lives.
The head of the medicine division of the Federation of Chambers of Commerce, Ali Ouf, revealed that a request will be submitted to the Egyptian Drug Authority early next week to move the prices of 1,500 items in light of what he described as developments in the situation and rising costs.
He pointed out that « the need to raise the wages of workers in the pharmaceutical sector to compensate them for the cost of living and therefore must raise salaries so that they can live in the current conditions and the sector will bear the increase of salaries at the expense of cost and raise the minimum insurance ».
On the shortage of medicines, Amin al-Dabraki, one of the dealers in the pharmaceutical market, said that the main reason for the crisis is the lack of active substances imported by companies.
This is mainly due to the dollar crisis, in addition to the withdrawal of some financial companies from the Egyptian pharmaceutical market.
On the inability of the Ministry of Health to move the prices of medicines with the movement of the exchange rate, he said that the solutions are the intervention of the state by providing a fixed customs dollar for pharmaceutical companies, while moving the prices of medicines, in addition to starting factories to produce active substances inside Egypt.

Government price controls may contribute to medication production shortages by limiting the supply price of generic drugs and reducing the return on investment in new drugs.